DOI: 10.36347/sjams.2020.v08i11.028

Pages: 2569-2572

Radionuclide synovectomy is an attractive alternative to surgical synovectomy for the management of the various joint diseases. Recently, the development of new radiopharmaceuticals labeled with 90Y, 32P, 186Re, 188Re, 153Sm, 165Dy and 166Ho, for the effective management of synovial inflammation and related arthritic pain is gaining attention. The background and mechanism, radiopharmaceuticals and injection methods, clinical applications and results, patient’s selection, assessment of efficacy, and complications and contraindications of radionuclide synovectomy are reviewed.